These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11682210)

  • 41. Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling.
    Narazaki M; Fujimoto M; Matsumoto T; Morita Y; Saito H; Kajita T; Yoshizaki K; Naka T; Kishimoto T
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13130-4. PubMed ID: 9789053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites.
    Lombardo CR; Consler TG; Kassel DB
    Biochemistry; 1995 Dec; 34(50):16456-66. PubMed ID: 8845374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of solvation sites at the interface of Src SH2 domain complexes using molecular dynamics simulations.
    Geroult S; Hooda M; Virdee S; Waksman G
    Chem Biol Drug Des; 2007 Aug; 70(2):87-99. PubMed ID: 17683370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Discovery Strategy for Selective Inhibitors of c-Src in Complex with the Focal Adhesion Kinase SH3/SH2-binding Region.
    Moroco JA; Baumgartner MP; Rust HL; Choi HG; Hur W; Gray NS; Camacho CJ; Smithgall TE
    Chem Biol Drug Des; 2015 Aug; 86(2):144-55. PubMed ID: 25376742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-affinity Src-SH2 ligands which do not activate Tyr(527)-phosphorylated Src in an experimental in vivo system.
    Mandine E; Jean-Baptiste V; Vayssière B; Gofflo D; Bénard D; Sarubbi E; Deprez P; Baron R; Superti-Furga G; Lesuisse D
    Biochem Biophys Res Commun; 2002 Oct; 298(2):185-92. PubMed ID: 12387813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of SH2-ligand interactions via library affinity selection with mass spectrometric detection.
    Kelly MA; Liang H; Sytwu II; Vlattas I; Lyons NL; Bowen BR; Wennogle LP
    Biochemistry; 1996 Sep; 35(36):11747-55. PubMed ID: 8794755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
    Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
    J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of phosphatidylinositol 3-kinase, via the SH2 domains of p85, with focal adhesion kinase in polyoma middle t-transformed fibroblasts.
    Bachelot C; Rameh L; Parsons T; Cantley LC
    Biochim Biophys Acta; 1996 Mar; 1311(1):45-52. PubMed ID: 8603102
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation of the phosphorylation states of pp60c-src with tyrosine kinase activity: the intramolecular pY530-SH2 complex retains significant activity if Y419 is phosphorylated.
    Boerner RJ; Kassel DB; Barker SC; Ellis B; DeLacy P; Knight WB
    Biochemistry; 1996 Jul; 35(29):9519-25. PubMed ID: 8755732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Computational and functional analysis of the putative SH2 domain in Janus Kinases.
    Kampa D; Burnside J
    Biochem Biophys Res Commun; 2000 Nov; 278(1):175-82. PubMed ID: 11071870
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design and biological evaluation of linear and cyclic phosphopeptide ligands of the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1.
    Imhof D; Wieligmann K; Hampel K; Nothmann D; Zoda MS; Schmidt-Arras D; Zacharias M; Böhmer FD; Reissmann S
    J Med Chem; 2005 Mar; 48(5):1528-39. PubMed ID: 15743195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phosphotyrosine-independent binding of a 62-kDa protein to the src homology 2 (SH2) domain of p56lck and its regulation by phosphorylation of Ser-59 in the lck unique N-terminal region.
    Park I; Chung J; Walsh CT; Yun Y; Strominger JL; Shin J
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12338-42. PubMed ID: 8618896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Examining the specificity of Src homology 3 domain--ligand interactions with alkaline phosphatase fusion proteins.
    Yamabhai M; Kay BK
    Anal Biochem; 1997 Apr; 247(1):143-51. PubMed ID: 9126384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of two proline-rich sequences of cell adhesion kinase beta with SH3 domains of p130Cas-related proteins and a GTPase-activating protein, Graf.
    Ohba T; Ishino M; Aoto H; Sasaki T
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1249-54. PubMed ID: 9494093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide.
    Ahn SC; Oh WK; Kim BY; Kang DO; Kim MS; Heo GY; Ahn JS
    Planta Med; 2003 Jul; 69(7):642-6. PubMed ID: 12898421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kinetics of p56lck and p60src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance.
    Payne G; Shoelson SE; Gish GD; Pawson T; Walsh CT
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):4902-6. PubMed ID: 7685110
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amino propynyl benzoic acid building block in rigid spacers of divalent ligands binding to the Syk SH2 domains with equally high affinity as the natural ligand.
    Dekker FJ; de Mol NJ; Fischer MJ; Liskamp RM
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1241-4. PubMed ID: 12657254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitor Library Screening of SH2 Domains Through Denaturation-Based Assays.
    de Araujo ED; Orlova A; Ashraf QF; Moriggl R; Gunning PT
    Methods Mol Biol; 2023; 2705():213-223. PubMed ID: 37668976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DRUGGING "UNDRUGGABLE" DISEASE-CAUSING PROTEINS: FOCUS ON SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STAT) 3.
    Tweardy DJ
    Trans Am Clin Climatol Assoc; 2022; 132():61-76. PubMed ID: 36196170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.